Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,953,260
in 5 filings, $6.0M under 10b5-1 plans

Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$6.0M Chief Executive Officer sold 41% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-27 Hunt Anthony Chief Executive Officer Shares withheld for taxes −2,754 $196.70 $542K 193,071
2022-02-27 Gebski Christine See Remarks Shares withheld for taxes −462 $196.70 $91K 35,025
2022-02-24 Hunt Anthony Chief Executive Officer Grant or award +15,855 196,995
2022-02-24 Hunt Anthony Chief Executive Officer Shares withheld for taxes −1,170 $189.21 $221K 195,825
2022-02-24 Hunt Anthony Chief Executive Officer Grant or award · Stock Option (Right to Buy) +20,307 20,307
2022-02-24 KURIYEL RALF Senior VP, R&D Grant or award +2,126 19,310
2022-02-24 KURIYEL RALF Senior VP, R&D Shares withheld for taxes −188 $189.21 $36K 19,122
2022-02-24 KURIYEL RALF Senior VP, R&D Grant or award · Stock Option (Right to Buy) +2,723 2,723
2022-02-24 Snodgres Jon Chief Financial Officer Grant or award +3,443 33,904
2022-02-24 Snodgres Jon Chief Financial Officer Shares withheld for taxes −269 $189.21 $51K 33,635
2022-02-24 Snodgres Jon Chief Financial Officer Grant or award · Stock Option (Right to Buy) +4,410 4,410
2022-02-24 Gebski Christine See Remarks Grant or award +2,124 35,668
2022-02-24 Gebski Christine See Remarks Shares withheld for taxes −181 $189.21 $34K 35,487
2022-02-24 Gebski Christine See Remarks Grant or award · Stock Option (Right to Buy) +2,721 2,721
2022-02-24 Bylund James Chief Operating Officer Grant or award +3,366 10,256
2022-02-24 Bylund James Chief Operating Officer Shares withheld for taxes −188 $189.21 $36K 10,068
2022-02-24 Bylund James Chief Operating Officer Grant or award · Stock Option (Right to Buy) +4,312 4,312
2022-02-17 Bylund James Chief Operating Officer Grant or award +900 7,224
2022-02-17 Bylund James Chief Operating Officer Shares withheld for taxes −334 $182.42 $61K 6,890
2022-02-17 KURIYEL RALF Senior VP, R&D Grant or award +450 17,359

Page 22 of 23 · 455 trades